New gel shows promise for Hard-to-Heal diabetic wounds

NCT ID NCT03888053

Completed Symptom relief Sponsor: Blue Blood Biotech Corp. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tested a topical gel called BB-101 in 14 adults with diabetic foot or leg ulcers. The goal was to see if the gel is safe and might help wounds heal faster when added to standard care. Participants received either the gel or a placebo, and researchers monitored side effects and healing over 4 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT ULCER

Contacts and locations

Show contact details

Locations

E-DA Hospital

Kaohsiung City, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, Taiwan
National Cheng Kung University Hospital

Tainan, Taiwan
Shin Kong Wu Ho-Su Memorial Hospital

Taipei, Taiwan
Shuangho Hospital

New Taipei City, Taiwan
Tri-Service General Hospital

Taipei, Taiwan